Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER_GOV × Burkitt Lymphoma × Clear all

Phase

Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 9 Papillomavirus Infections 4 Lymphoma, Non-Hodgkin 4 Hypertension, Portal 4 Febrile Neutropenia 4 Carcinoma, Non-Small-Cell Lung 4 Polycystic Ovary Syndrome 3 Multiple Myeloma 3 Lung Neoplasms 3 Cancer Pain 3 Adenomatous Polyposis Coli 3 Recurrence 2 Prostatic Hyperplasia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Ovarian Cysts 2 Neoplasms 2 Lymphoma, B-Cell 2 Lymphoma 2 Liver Cirrhosis 2 Leiomyoma 2 Infertility 2 Hematologic Neoplasms 2 Vomiting 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Surgical Wound Infection 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Sprains and Strains 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02618109 2022-10-03

LABMI

University Hospital, Angers

Phase 4 Terminated

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡